NATHBIOGEN

Nath Bio-Genes (India) Ltd.

NSE: NATHBIOGEN

BSE: 537291

Sector: Fast Moving Consumer Goods

Industry Group: Agricultural Food & other Products

Industry: Other Agricultural Products

134.20-3.5 (-2.57%)

5 Oct, 3:30 PM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

23.3 / 100

Value Score

92.6 / 100

Price Momentum Score

42.7 / 100

QVM Score

53.2 / 100

Key Metrics

Market Cap

265.58

P/E (TTM)

7.25

P/B

0.39

P/S (TTM)

0.54

EV/EBITDA

3.34

CAPE (5Y)

18.59

ROE (TTM)

6.28

ROCE (TTM)

6.11

ROA (TTM)

3.92

Avg 3Y ROE

6.38

Earnings 3Y CAGR

-2.21

Sales 3Y CAGR

14.38

Sales 5Y CAGR

8.29

Debt/Equity

0.20

Consensus TP

Strong Buy %

Promoter Holding

45.60

Pledged %

13.78

Stock Analysis

Fundamental analysis overview of Nath Bio-Genes (India) Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 7.25 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -51.31%

What is P/E Ratio?

Median: 14.89

Value 7.25

1.16439.38

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 21.02% for 12-month ended 30 Jun 2026 and the growth was 14.22 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 6.8

Value 21.02

-91.765336.1

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.2 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.01 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 5 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Low but stable ROE

The company reported low ROE of 6.28% for 12-month ended 30 Jun 2026 and ROE improved marginally by 12 bps from 1 year ago

What is ROE (FY)?

Low and declining operating margin

The company reported low operating margin of 9.25% for 12-month ended 30 Jun 2026 and operating margin declined by -250 bps from 1 year ago

What is Operating profit margin?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -12.89% for 12-month ended 30 Jun 2026 and the growth was 16.08 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 37.6 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

37.6 / 100

Moderate dividend yield

The company has a moderate dividend yield of 1.43%

What is Dividend yield?

Financial Snapshot

See detailed analysis

Multi-year trends for Nath Bio-Genes (India) Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Nath Bio-Genes (India) Ltd. Shareholding Pattern

Quarterly breakdown of Nath Bio-Genes (India) Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	41.79	41.79	41.79	41.79	40.86	41.03	41.03	41.03	41.05	41.07	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60
Indian Promoter	41.79	41.79	41.79	41.79	40.86	41.03	41.03	41.03	41.05	41.07	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	9.03	11.04	11.04	11.04	11.05	11.05	9.39	7.21	4.92	4.73	4.63	4.77	4.75	4.70	4.59	4.69	4.64	4.59	4.55	4.56	4.15	2.67	1.08	0.32	0.24	0.28
Mutual Funds / UTI	6.27	8.55	8.55	8.55	8.55	8.55	8.44	7.16	4.85	4.62	4.62	4.62	4.62	4.62	4.37	4.37	4.37	4.37	4.37	4.37	3.89	2.25	0.76	0.01	0.01	0.01
FI/Bank/Insurance	0.27	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.17	0.17	0.17	0.17	0.18	0.18	0.01	0.04	0.07	0.11	0.01	0.15	0.13	0.07	0.22	0.32	0.27	0.21	0.18	0.19	0.21	0.41	0.32	0.31	0.22	0.26
Other Institutions	2.31	2.31	2.31	2.31	2.31	2.31	0.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.05	0.00	0.00	0.00	0.00	0.00
Non-Institution	49.18	47.16	47.17	47.17	48.10	47.92	49.58	51.76	54.02	54.20	49.77	49.63	49.65	49.71	49.81	49.72	49.76	49.82	49.85	49.84	50.25	51.74	53.32	54.08	54.17	54.13
Bodies Corporate	21.60	19.25	18.96	20.71	22.22	22.53	22.76	21.92	19.70	18.52	13.43	14.19	14.79	14.61	14.41	14.28	13.14	12.97	13.84	13.79	13.84	13.62	14.23	14.46	14.70	14.54
Others (incl. Retail) No. of shareholders	27.58 23,230	27.91 23,700	28.21 26,928	26.46 27,007	25.88 25,214	25.39 31,248	26.82 32,847	29.84 33,506	34.32 35,197	35.68 35,086	36.34 35,068	35.44 34,350	34.86 33,571	35.10 33,117	35.40 33,982	35.44 33,879	36.62 34,755	36.85 35,463	36.01 35,029	36.05 34,654	36.41 34,519	38.12 33,822	39.09 33,736	39.62 33,173	39.47 32,659	39.59 32,198

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Nath Bio-Genes (India) Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Nath Bio-Genes (India) Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
AGRI-TECH INDIA LIMITED Promoter Group	February-2024	Inter-se Transfer (Disposal) 21st Feb 2024	2.65 %	₹ 217.00	5.04 lac	₹ 10.94 cr
AKASH FARMS LLP Promoter Group	February-2024	Inter-se Transfer (Acquisition) 21st Feb 2024	9.59 %	₹ 217.00	5.04 lac	₹ 10.94 cr
AGRI-TECH INDIA LIMITED Promoter Group	December-2023	Inter-se Transfer (Disposal) 25th Dec 2023	3.54 %	₹ 211.00	1.69 lac	₹ 3.56 cr
BARKHA FARMS LLP Promoter Group	December-2023	Inter-se Transfer (Acquisition) 25th Dec 2023	1.86 %	₹ 211.00	1.69 lac	₹ 3.56 cr
AGRI-TECH INDIA LIMITED Promoter Group	December-2023	Market Sale (Disposal) 18th Dec 2023	5.18 %	₹ 199.25	3.12 lac	₹ 6.21 cr
AKASH FARMS LLP Promoter Group	December-2023	Market Purchase (Acquisition) 18th Dec 2023	7.95 %	₹ 199.25	3.12 lac	₹ 6.21 cr
AGRI-TECH INDIA LIMITED Promoter Group	December-2023	Inter-se Transfer (Disposal) 12th Dec 2023	7.87 %	₹ 196.00	5.11 lac	₹ 10.01 cr
ASHU FARMS LLP Promoter Group	December-2023	Inter-se Transfer (Acquisition) 12th Dec 2023	10.99 %	₹ 196.00	5.11 lac	₹ 10.01 cr
EMERALD SEEDS PRIVATE LIMITED Other	August-2022	Market Purchase (Acquisition) 26th Aug 2022	0.00 %	₹ 180.06	6.90 lac	₹ 12.42 cr
AGRI-TECH INDIA LIMITED Promoter Group	August-2022	Market Purchase (Acquisition) 26th Aug 2022	6.97 %	₹ 176.94	1.70 lac	₹ 3.01 cr

Corporate Actions

History of Nath Bio-Genes (India) Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 2/share
Record date: 11th Sep 2026Ex-date: 11th Sep 2026
Announced on: 4th May 2026
Dividend₹ 2/share
Record date: 14th Aug 2025Ex-date: 14th Aug 2025
Announced on: 29th Apr 2025
Dividend₹ 2/share
Record date: 9th Aug 2024Ex-date: 9th Aug 2024
Announced on: 8th May 2024
Dividend₹ 2/share
Record date: 4th Jul 2023Ex-date: 4th Jul 2023
Announced on: 25th Apr 2023
Dividend₹ 2/share
Record date: 24th Jun 2022Ex-date: 23rd Jun 2022
Announced on: 30th May 2022

Company Profile

Overview of Nath Bio-Genes (India) Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Nath Bio-Genes (India) Limited is an India-based company engaged in the business of production, processing, and marketing of hybrid and genetically modified (GM) Seeds. The Company has a product range of field crops, vegetable crops and plant nutrient supplements. The major processing plants are sit...

Key personnel

Mr. Amol Gupta

Chief Financial Officer

Mr. Dhiraj Rajesh Rathi

Compliance Officer, Company Secretary

Mr. Satish KagliwalD

Managing Director, Director

Mrs. Jeevanlata Nandkishor KagliwalD

Executive Director

Mr. Akash Nandkishor KagliwalD

Non-Executive Director

Mr. Madhukar DeshpandeD

Independent Director

Mr. Vadla NagabhushanamD

Independent Director

Mr. Hitesh Rajnikant PurohitD

Independent Director

View all

Incorporated on

14 Jul 1993

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

452

IPO date

28 Jan 2014

Free Float

72,79,264

Website

https://nathbiogenes.com/

Phone no.

+912222871001

Address

1, Chateau Windsor,, 86 Veer Nariman Road,, Churchgate, MUMBAI, 400020, India

Frequently Asked Questions

What is the current share price of Nath Bio-Genes (India) Ltd.?

The current share price of Nath Bio-Genes (India) Ltd. is ₹ 134.20 as of 5 Oct 2026.

What is the market capitalisation of Nath Bio-Genes (India) Ltd.?

The market capitalisation of Nath Bio-Genes (India) Ltd. stands at ₹ 265.58 Cr.

What is the PE ratio of Nath Bio-Genes (India) Ltd.?

The Price-to-Earnings (PE) ratio of Nath Bio-Genes (India) Ltd. is 7.25 as of the latest trailing twelve months data.

What is the ROE and ROCE of Nath Bio-Genes (India) Ltd.?

Nath Bio-Genes (India) Ltd. has a Return on Equity (ROE) of 6.28% and a Return on Capital Employed (ROCE) of 6.11% as per the latest financial reports.

What is the 52-week high and low of Nath Bio-Genes (India) Ltd.?

The 52-week high of Nath Bio-Genes (India) Ltd. is - and the 52-week low is -.

What is the dividend yield of Nath Bio-Genes (India) Ltd.?

The dividend yield of Nath Bio-Genes (India) Ltd. is 1.43% based on the current market price.

What is the FII and DII holding in Nath Bio-Genes (India) Ltd.?

Foreign Institutional Investors (FII) hold 0.26%, Domestic Institutional Investors (DII) hold 0.01% and retail/public investors hold 39.59% of Nath Bio-Genes (India) Ltd. shares.

What sector does Nath Bio-Genes (India) Ltd. belong to?

Nath Bio-Genes (India) Ltd. operates in the Fast Moving Consumer Goods sector.

What is the beta of Nath Bio-Genes (India) Ltd.?

The beta of Nath Bio-Genes (India) Ltd. is 0.93, indicating its price volatility relative to the broader market. Over the past 1 year, Nath Bio-Genes (India) Ltd. has delivered an absolute return of -18.46%.

What is the RSI of Nath Bio-Genes (India) Ltd.?

The 14-day Relative Strength Index (RSI) of Nath Bio-Genes (India) Ltd. is 32.37, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Nath Bio-Genes (India) Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Nath Bio-Genes (India) Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Company Profile

Corporate Actions

Holdings and Presence

Stock Analysis